The first vaccines to guard against the respiratory illness RSV will soon be available for some older adults, ages 60 and over, after the CDC formally backed recommendations for the shots.

“We’ve stepped back into the world that we lived in before the [CDC’s vaccine advisory committee] was created,” said Dr.

How many New Yorkers received RSV vaccine so far About 20% of New Yorkers ages 60 and older received the RSV vaccine as of May, federal data shows, which is slightly below the national average of 24%.

Previously, vaccination against RSV was only recommended for use in adults aged 60 years and older, per the CDC. The new recommendations replace the previous guidance. The CDC update was made to ...

Between 60,000 to 160,000 older adults in the U.S. are hospitalized due to RSV every year and 6,000 to 10,000 of them die, the CDC said.

Fact checked by Jennifer Klump Although respiratory syncytial virus (RSV) is often associated with children, adults can also ...

Prior to this, the CDC recommended that everyone over the age of 60 have the option of receiving an RSV vaccine dose. “This recommendation is for adults who did not get an RSV vaccine last year.

Americans age 60 and older can get a single dose of an RSV vaccine following a conversation with their doctor, the Centers for Disease Control and Prevention (CDC) recommended Thursday. CDC Directo… ...

In June, the CDC gave its approval to both Abrysvo and GSK's Arexvy vaccine as protections against RSV for adults ages 60 and older. The previous month, Arexvy became the first RSV vaccine to ever ...

In a nearly unanimous vote, advisors to the Centers for Disease Control and Prevention have recommended a new vaccine to protect infants from respiratory syncytial virus, or RSV, by vaccinating ...

More RSV vaccines may be on the way, too. Moderna is finishing its Phase 3 trial of an mRNA vaccine for RSV in older adults and expects to submit results to the FDA within the next few months.

The CDC also plans to use V-Safe, a program developed specifically to monitor Covid-19 vaccine safety that has been redesigned to track other people’s post-vaccine experience with other vaccines.